BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1039112 COc1ccc(cc1)C1CN(C1)C(=O)CC1CCN(C1)C#N InChI=1S/C17H21N3O2/c1-22-16-4-2-14(3-5-16)15-10-20(11-15)17(21)8-13-6-7-19(9-13)12-18/h2-5,13,15H,6-11H2,1H3 ORKDWGOHENYQPI-UHFFFAOYSA-N 498825 US11014912, Example 1 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498825&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400122 459071704 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039113 Clc1cccc(NC(=O)CC2CCN(C2)C#N)c1 InChI=1S/C13H14ClN3O/c14-11-2-1-3-12(7-11)16-13(18)6-10-4-5-17(8-10)9-15/h1-3,7,10H,4-6,8H2,(H,16,18) AXPMSQIOXVAZHM-UHFFFAOYSA-N 498826 N-(3-Chlorophenyl)-2-(1- cyanopyrrolidin-3-yl)acetamide::US11014912, Example 2 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498826&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757228 459071705 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039114 COc1ccc2nc(NC(=O)CC3CCN(C3)C#N)sc2c1 InChI=1S/C15H16N4O2S/c1-21-11-2-3-12-13(7-11)22-15(17-12)18-14(20)6-10-4-5-19(8-10)9-16/h2-3,7,10H,4-6,8H2,1H3,(H,17,18,20) HDSDEAKVBLFLNV-UHFFFAOYSA-N 498827 2-(1-Cyanopyrrolidin-3-yl)-N-(6- methoxybenzo[d]thiazol-2- yl)acetamide::US11014912, Example 3 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498827&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757262 459071706 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039115 FC(F)(F)c1ccc(NC(=O)CC2CCN(C2)C#N)cn1 InChI=1S/C13H13F3N4O/c14-13(15,16)11-2-1-10(6-18-11)19-12(21)5-9-3-4-20(7-9)8-17/h1-2,6,9H,3-5,7H2,(H,19,21) QHFDHQFPHQDHPC-UHFFFAOYSA-N 498828 2-(1-Cyanopyrrolidin-3-yl)-N-(6- (trifluoromethyl)pyridin-3- yl)acetamide::US11014912, Example 4 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498828&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757255 459071707 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039116 Clc1ccc2nc(NC(=O)CC3CCN(C3)C#N)sc2c1 InChI=1S/C14H13ClN4OS/c15-10-1-2-11-12(6-10)21-14(17-11)18-13(20)5-9-3-4-19(7-9)8-16/h1-2,6,9H,3-5,7H2,(H,17,18,20) WJVZAJWHDFNQMK-UHFFFAOYSA-N 498829 N-(6-Chlorobenzo[d]thiazol-2- yl)-2-(1-cyanopyrrolidin-3- yl)acetamide::US11014912, Example 5 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498829&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757242 459071708 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039117 O=C(CC1CCN(C1)C#N)Nc1cc(no1)-c1ccccc1 InChI=1S/C16H16N4O2/c17-11-20-7-6-12(10-20)8-15(21)18-16-9-14(19-22-16)13-4-2-1-3-5-13/h1-5,9,12H,6-8,10H2,(H,18,21) MWXORCURPAWGGU-UHFFFAOYSA-N 498830 2-(1-Cyanopyrrolidin-3-yl)-N-(3- phenylisoxazol-5-yl)acetamide::US11014912, Example 6 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498830&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 153311693 459071709 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039118 O=C(CC1CCN(C1)C#N)NC1CCC(N1)c1ccccc1 InChI=1S/C17H22N4O/c18-12-21-9-8-13(11-21)10-17(22)20-16-7-6-15(19-16)14-4-2-1-3-5-14/h1-5,13,15-16,19H,6-11H2,(H,20,22) BYWMTCWRHZSJQC-UHFFFAOYSA-N 498831 2-(1-Cyanopyrrolidin-3-yl)-N-(5- phenylpyrrolidin-2-yl)acetamide::US11014912, Example 7 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498831&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 149859551 459071710 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039119 Clc1ccc2oc(NC(=O)CC3CCN(C3)C#N)nc2c1 InChI=1S/C14H13ClN4O2/c15-10-1-2-12-11(6-10)17-14(21-12)18-13(20)5-9-3-4-19(7-9)8-16/h1-2,6,9H,3-5,7H2,(H,17,18,20) SKQUMOXBGLBYIJ-UHFFFAOYSA-N 498832 N-(5-Chlorobenzo[d]oxazol-2- yl)-2-(1-cyanopyrrolidin-3- yl)acetamide::US11014912, Example 8 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498832&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314450 459071711 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039120 Clc1ccc(NC(=O)CC2CCN(C2)C#N)cc1Cl InChI=1S/C13H13Cl2N3O/c14-11-2-1-10(6-12(11)15)17-13(19)5-9-3-4-18(7-9)8-16/h1-2,6,9H,3-5,7H2,(H,17,19) FMFROMHKOHQWMQ-UHFFFAOYSA-N 498833 2-(1-Cyanopyrrolidin-3-yl)-N- (3,4-dichlorophenyl)acetamide::US11014912, Example 9 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498833&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757223 459071712 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039121 O=C(CC1CCN(C1)C#N)Nc1ncc(s1)-c1ccccc1 InChI=1S/C16H16N4OS/c17-11-20-7-6-12(10-20)8-15(21)19-16-18-9-14(22-16)13-4-2-1-3-5-13/h1-5,9,12H,6-8,10H2,(H,18,19,21) HTJKNMMLXKULIN-UHFFFAOYSA-N 498834 2-(1- Cyanopyrrolidin-3- yl)-N-(5- phenylthiazol-2- yl)acetamide::US11014912, Example 10 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498834&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757249 459071713 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039122 O=C(CC1CCN(C1)C#N)NCCc1ccccc1 InChI=1S/C15H19N3O/c16-12-18-9-7-14(11-18)10-15(19)17-8-6-13-4-2-1-3-5-13/h1-5,14H,6-11H2,(H,17,19) SRASKPJBHKNSRL-UHFFFAOYSA-N 498835 2-(1- Cyanopyrrolidin-3- yl)-N- phenethylacetamide::US11014912, Example 11 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498835&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757193 459071714 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039123 O=C(CC1CCN(C1)C#N)N1CC(C1)Oc1ccccc1 InChI=1S/C16H19N3O2/c17-12-18-7-6-13(9-18)8-16(20)19-10-15(11-19)21-14-4-2-1-3-5-14/h1-5,13,15H,6-11H2 LOOVWGPXPRGBFR-UHFFFAOYSA-N 498836 3-(2-Oxo-2-(3- phenoxyazetidin-1- yl)ethyl)pyrrolidine- 1-carbonitrile::US11014912, Example 12 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498836&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757229 459071715 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039124 COc1cccc(c1)C1CN(C1)C(=O)CC1CCN(C1)C#N InChI=1S/C17H21N3O2/c1-22-16-4-2-3-14(8-16)15-10-20(11-15)17(21)7-13-5-6-19(9-13)12-18/h2-4,8,13,15H,5-7,9-11H2,1H3 KIXBWBXOMKSLCW-UHFFFAOYSA-N 498837 3-(2-(3-(3- Methoxyphenyl) azetidin-1-yl)-2- oxoethyl)pyrrolidine- 1-carbonitrile::US11014912, Example 13 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498837&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757199 459071716 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039125 Fc1ccc(cc1F)C1CN(C1)C(=O)CC1CCN(C1)C#N InChI=1S/C16H17F2N3O/c17-14-2-1-12(6-15(14)18)13-8-21(9-13)16(22)5-11-3-4-20(7-11)10-19/h1-2,6,11,13H,3-5,7-9H2 XLKWTKAHXKPHGV-UHFFFAOYSA-N 498838 2-(1- Cyanopyrrolidin-3- yl)-N-(3,4- dichlorophenyl) acetamide::US11014912, Example 14 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498838&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757243 459071717 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039126 Cc1cc(ccn1)C1CN(C1)C(=O)CC1CCN(C1)C#N InChI=1S/C16H20N4O/c1-12-6-14(2-4-18-12)15-9-20(10-15)16(21)7-13-3-5-19(8-13)11-17/h2,4,6,13,15H,3,5,7-10H2,1H3 ZPKYHZNBILANFJ-UHFFFAOYSA-N 498839 3-(2-(3-(2- Methylpyridin-4- yl)azetidin-1-yl)-2- oxoethyl)pyrrolidine- 1-carbonitrile::US11014912, Example 15 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498839&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757214 459071718 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039127 Cc1noc(C)c1-c1ccc2nc(NC(=O)CC3CCN(C3)C#N)cn2c1 InChI=1S/C19H20N6O2/c1-12-19(13(2)27-23-12)15-3-4-17-21-16(10-25(17)9-15)22-18(26)7-14-5-6-24(8-14)11-20/h3-4,9-10,14H,5-8H2,1-2H3,(H,22,26) ACFBKIRZSKQCAR-UHFFFAOYSA-N 498840 2-(1-Cyanopyrrolidin-3-yl)-N-(6-(3,5-dimethylisoxazol-4-yl)imidazo[1,2-a]pyridin-2-yl)acetamide::US11014912, Example 16 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498840&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400214 459071719 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039128 COc1ccc(cc1)C1CN(C1)C(=O)C=C1CCN(C1)C#N InChI=1S/C17H19N3O2/c1-22-16-4-2-14(3-5-16)15-10-20(11-15)17(21)8-13-6-7-19(9-13)12-18/h2-5,8,15H,6-7,9-11H2,1H3/b13-8+ MSTJQLWIQKLIBX-MDWZMJQESA-N 498841 US11014912, Example 17 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498841&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 162369423 459071720 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039129 O=C(C=C1CCN(C1)C#N)N1CC(C1)c1ccccc1 InChI=1S/C16H17N3O/c17-12-18-7-6-13(9-18)8-16(20)19-10-15(11-19)14-4-2-1-3-5-14/h1-5,8,15H,6-7,9-11H2/b13-8+ LWKQVPPTSGJAQD-MDWZMJQESA-N 498842 3-(2-Oxo-2-(3-phenylazetidin-1-yl)ethylidene)pyrrolidine-1-carbonitrile::US11014912, Example 18 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498842&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757254 459071721 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039130 Cc1ccc(NC(=O)C=C2CCN(C2)C#N)cc1Cl InChI=1S/C14H14ClN3O/c1-10-2-3-12(7-13(10)15)17-14(19)6-11-4-5-18(8-11)9-16/h2-3,6-7H,4-5,8H2,1H3,(H,17,19)/b11-6- VHQWHRUTWDTZDG-WDZFZDKYSA-N 498843 N-(3-Chloro-4-methylphenyl)- 2-(1-cyanopyrrolidin-3- ylidene)acetamide::US11014912, Example 19 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498843&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283996 459071722 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039131 FC(F)(F)c1cc(NC(=O)C=C2CCN(C2)C#N)ccc1Cl InChI=1S/C14H11ClF3N3O/c15-12-2-1-10(6-11(12)14(16,17)18)20-13(22)5-9-3-4-21(7-9)8-19/h1-2,5-6H,3-4,7H2,(H,20,22)/b9-5+ SMYLWKOVYRDLIH-WEVVVXLNSA-N 498844 N-(4-Chloro-3- (trifluoromethyl)phenyl)-2-(1- cyanopyrrolidin-3- ylidene)acetamide::US11014912, Example 20 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498844&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 162369424 459071723 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039132 O=C(Nc1ccc2ncsc2c1)C=C1CCN(C1)C#N InChI=1S/C14H12N4OS/c15-8-18-4-3-10(7-18)5-14(19)17-11-1-2-12-13(6-11)20-9-16-12/h1-2,5-6,9H,3-4,7H2,(H,17,19)/b10-5+ DHKVGZNLTTUFQA-BJMVGYQFSA-N 498845 N-(Benzo[d]thiazol-6-yl)-2-(1- cyanopyrrolidin-3- ylidene)acetamide::US11014912, Example 21 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498845&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283987 459071724 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039133 O=C(Nc1ccc(Oc2ccccc2)cc1)C=C1CCN(C1)C#N InChI=1S/C19H17N3O2/c20-14-22-11-10-15(13-22)12-19(23)21-16-6-8-18(9-7-16)24-17-4-2-1-3-5-17/h1-9,12H,10-11,13H2,(H,21,23)/b15-12- ZZUCVVWFPFKJIN-QINSGFPZSA-N 498846 2-(1-Cyanopyrrolidin-3- ylidene)-N-(4- phenoxyphenyl)acetamide::US11014912, Example 22 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498846&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283981 459071725 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039134 O=C(Nc1cnc2ccccc2c1)C=C1CCN(C1)C#N InChI=1S/C16H14N4O/c17-11-20-6-5-12(10-20)7-16(21)19-14-8-13-3-1-2-4-15(13)18-9-14/h1-4,7-9H,5-6,10H2,(H,19,21)/b12-7- CKSSCSXMCXCDJL-GHXNOFRVSA-N 498847 2-(1-Cyanopyrrolidin-3- ylidene)-N-(quinolin-3- yl)acetamide::US11014912, Example 23 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498847&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283979 459071726 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039135 CN(Cc1ccc2ncccc2c1)C(=O)C=C1CCN(C1)C#N InChI=1S/C18H18N4O/c1-21(18(23)10-15-6-8-22(12-15)13-19)11-14-4-5-17-16(9-14)3-2-7-20-17/h2-5,7,9-10H,6,8,11-12H2,1H3/b15-10- HCAAYOJIJKAMNI-GDNBJRDFSA-N 498848 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-(quinolin- 6-ylmethyl)acetamide::US11014912, Example 24 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498848&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284020 459071727 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039136 CN(Cc1cc(on1)-c1ccccc1)C(=O)C=C1CCN(C1)C#N InChI=1S/C18H18N4O2/c1-21(18(23)9-14-7-8-22(11-14)13-19)12-16-10-17(24-20-16)15-5-3-2-4-6-15/h2-6,9-10H,7-8,11-12H2,1H3/b14-9- BIQWNFIYLGZZIW-ZROIWOOFSA-N 498849 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-((5- phenylisoxazol-3- yl)methyl)acetamide::US11014912, Example 25 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498849&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284008 459071728 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039137 CN(Cc1cccc(c1)-c1ccncc1)C(=O)C=C1CCN(C1)C#N InChI=1S/C20H20N4O/c1-23(20(25)12-17-7-10-24(14-17)15-21)13-16-3-2-4-19(11-16)18-5-8-22-9-6-18/h2-6,8-9,11-12H,7,10,13-14H2,1H3/b17-12- XSHDNCVIWDMHQZ-ATVHPVEESA-N 498850 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-(3- (pyridin-4-yl)benzyl)acetamide::US11014912, Example 26 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498850&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283997 459071729 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039138 CN(Cc1cc(no1)-c1ccccc1)C(=O)C=C1CCN(C1)C#N InChI=1S/C18H18N4O2/c1-21(18(23)9-14-7-8-22(11-14)13-19)12-16-10-17(20-24-16)15-5-3-2-4-6-15/h2-6,9-10H,7-8,11-12H2,1H3/b14-9- AAHPDBORUYUVBD-ZROIWOOFSA-N 498851 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-((3- phenylisoxazol-5- yl)methyl)acetamide::US11014912, Example 27 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498851&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283991 459071730 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039139 CN(Cc1ccc(cc1)N1CCCC1)C(=O)C=C1CCN(C1)C#N InChI=1S/C19H24N4O/c1-21(19(24)12-17-8-11-22(14-17)15-20)13-16-4-6-18(7-5-16)23-9-2-3-10-23/h4-7,12H,2-3,8-11,13-14H2,1H3/b17-12- PKDVVBWNBMWWKW-ATVHPVEESA-N 498852 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-(4- (pyrrolidin-1- yl)benzyl)acetamide::US11014912, Example 28 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498852&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284022 459071731 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039140 CNC(=O)C(Cc1csc(n1)-c1ccccc1)=C1CCN(C1)C#N InChI=1S/C18H18N4OS/c1-20-17(23)16(14-7-8-22(10-14)12-19)9-15-11-24-18(21-15)13-5-3-2-4-6-13/h2-6,11H,7-10H2,1H3,(H,20,23)/b16-14- FCVYNVXGWZMGJS-PEZBUJJGSA-N 498853 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-((2- phenylthiazol-4- yl)methyl)acetamide::US11014912, Example 29 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498853&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 156377397 459071732 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039141 CN(Cc1cc(n[nH]1)-c1ccccc1)C(=O)C=C1CCN(C1)C#N InChI=1S/C18H19N5O/c1-22(18(24)9-14-7-8-23(11-14)13-19)12-16-10-17(21-20-16)15-5-3-2-4-6-15/h2-6,9-10H,7-8,11-12H2,1H3,(H,20,21)/b14-9- SXUXAPIBZPBPIP-ZROIWOOFSA-N 498854 2-(1-Cyanopyrrolidin-3- ylidene)-N-methyl-N-((5- phenyl-1H-pyrazol-3- yl)methyl)acetamide::US11014912, Example 30 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498854&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284007 459071733 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039142 Fc1ccc(cc1CNC(=O)C=C1CCN(C1)C#N)C(F)(F)F InChI=1S/C15H13F4N3O/c16-13-2-1-12(15(17,18)19)6-11(13)7-21-14(23)5-10-3-4-22(8-10)9-20/h1-2,5-6H,3-4,7-8H2,(H,21,23)/b10-5- RZNLMKLIBSPKEV-YHYXMXQVSA-N 498855 2-(1-Cyanopyrrolidin-3- ylidene)-N-(2-fluoro-5- (trifluoromethyl)benzyl) acetamide::US11014912, Example 31 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498855&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283989 459071734 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039143 CN(C(=O)C=C1CCN(C1)C#N)c1nc2ccccc2s1 InChI=1S/C15H14N4OS/c1-18(14(20)8-11-6-7-19(9-11)10-16)15-17-12-4-2-3-5-13(12)21-15/h2-5,8H,6-7,9H2,1H3/b11-8+ OBNZTEUSEIKFEG-DHZHZOJOSA-N 498856 N-(Benzo[d]thiazol-2-yl)-2-(1- cyanopyrrolidin-3-ylidene)-N- methylacetamide::US11014912, Example 32 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498856&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284001 459071735 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039144 CN(Cc1ccc(Cl)c(Cl)c1)C(=O)C=C1CCN(C1)C#N InChI=1S/C15H15Cl2N3O/c1-19(8-11-2-3-13(16)14(17)6-11)15(21)7-12-4-5-20(9-12)10-18/h2-3,6-7H,4-5,8-9H2,1H3/b12-7- GBFRGVDNEZJFHK-GHXNOFRVSA-N 498857 2-(1-Cyanopyrrolidin-3- ylidene)-N-(3,4- dichlorobenzyl)-N- methylacetamide::US11014912, Example 33 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498857&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155283986 459071736 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039145 Clc1ccc(cc1)-c1cc(NC(=O)C[C@@H]2CCN(C2)C#N)on1 InChI=1S/C16H15ClN4O2/c17-13-3-1-12(2-4-13)14-8-16(23-20-14)19-15(22)7-11-5-6-21(9-11)10-18/h1-4,8,11H,5-7,9H2,(H,19,22)/t11-/m0/s1 HNMUEYDSOZNGRA-NSHDSACASA-N 498858 (S)—N-(3-(4-Chlorophenyl)isoxazol-5-yl)-2-(1-cyanopyrrolidin-3-yl)acetamide::US11014912, Example 34 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498858&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400298 459071737 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039146 Clc1ccc(cc1)-c1cc(NC(=O)C[C@H]2CCN(C2)C#N)on1 InChI=1S/C16H15ClN4O2/c17-13-3-1-12(2-4-13)14-8-16(23-20-14)19-15(22)7-11-5-6-21(9-11)10-18/h1-4,8,11H,5-7,9H2,(H,19,22)/t11-/m1/s1 HNMUEYDSOZNGRA-LLVKDONJSA-N 498859 (R)—N-(3-(4-Chlorophenyl)isoxazol-5-yl)-2-(1-cyanopyrrolidin-3-yl)acetamide::US11014912, Example 35 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498859&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400148 459071738 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039147 Clc1cccc(c1)-c1cc(NC(=O)C[C@H]2CCN(C2)C#N)on1 InChI=1S/C16H15ClN4O2/c17-13-3-1-2-12(7-13)14-8-16(23-20-14)19-15(22)6-11-4-5-21(9-11)10-18/h1-3,7-8,11H,4-6,9H2,(H,19,22)/t11-/m1/s1 DSBRXBQUNFFWBD-LLVKDONJSA-N 498860 (R)—N-(3-(3-Chlorophenyl)isoxazol-5-yl)-2-(1-cyanopyrrolidin-3-yl)acetamide::US11014912, Example 36 Ubiquitin carboxyl-terminal hydrolase 30 Human 5.5 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498860&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400303 459071739 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039148 COc1cccc(c1)-c1cc(NC(=O)C[C@@H]2CCN(C2)C#N)on1 InChI=1S/C17H18N4O3/c1-23-14-4-2-3-13(8-14)15-9-17(24-20-15)19-16(22)7-12-5-6-21(10-12)11-18/h2-4,8-9,12H,5-7,10H2,1H3,(H,19,22)/t12-/m0/s1 UGTOHJBLJZBSKU-LBPRGKRZSA-N 498861 (S)—N-(3-(3-Methoxyphenyl)isoxazol-5-yl)-2-(1-cyanopyrrolidin-3-yl)acetamide::US11014912, Example 37 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498861&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400304 459071740 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039149 COc1ccc(cc1)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C17H21N3O2/c1-22-16-4-2-14(3-5-16)15-10-20(11-15)17(21)8-13-6-7-19(9-13)12-18/h2-5,13,15H,6-11H2,1H3/t13-/m0/s1 ORKDWGOHENYQPI-ZDUSSCGKSA-N 498862 US11014912, Example 38 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498862&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400147 459071741 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039150 COc1ccc(cc1-c1ccnn1C(=O)OC(C)(C)C)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C(=O)OC(C)(C)C InChI=1S/C29H40N4O6/c1-28(2,3)38-26(35)31-13-11-19(16-31)14-25(34)32-17-21(18-32)20-8-9-24(37-7)22(15-20)23-10-12-30-33(23)27(36)39-29(4,5)6/h8-10,12,15,19,21H,11,13-14,16-18H2,1-7H3/t19-/m0/s1 YOBSWRMNEKCFMT-IBGZPJMESA-N 498863 (S)-3-(2-(3-(4-Methoxy-3-(1H-pyrazol-5-yl)phenyl)azetidin-1-yl)-2-oxoethyl)pyrrolidine-1-carbonitrile::US11014912, Example 39 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498863&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400125 459071742 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039151 COc1ccc(cc1-c1ccnn1C)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C21H25N5O2/c1-24-19(5-7-23-24)18-10-16(3-4-20(18)28-2)17-12-26(13-17)21(27)9-15-6-8-25(11-15)14-22/h3-5,7,10,15,17H,6,8-9,11-13H2,1-2H3/t15-/m0/s1 HUYIBNKTKQMJBQ-HNNXBMFYSA-N 498864 (S)-3-(2-(3-(4-Methoxy-3-(1-methyl-1H-pyrazol-5-yl)phenyl)azetidin-1-yl)-2-oxoethyl)-pyrrolidine-1-carbonitrile::US11014912, Example 40 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498864&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 134400149 459071743 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039152 O=C(CC1CCN(C1)C#N)Nc1nnc(s1)-c1ccccc1 InChI=1S/C15H15N5OS/c16-10-20-7-6-11(9-20)8-13(21)17-15-19-18-14(22-15)12-4-2-1-3-5-12/h1-5,11H,6-9H2,(H,17,19,21) ZFIXWRFMOBNIJI-UHFFFAOYSA-N 498865 US11014912, Example 41 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498865&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757215 459071744 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039153 Clc1cccc(c1)-c1cc(NC(=O)C[C@@H]2CCN(C2)C#N)on1 InChI=1S/C16H15ClN4O2/c17-13-3-1-2-12(7-13)14-8-16(23-20-14)19-15(22)6-11-4-5-21(9-11)10-18/h1-3,7-8,11H,4-6,9H2,(H,19,22)/t11-/m0/s1 DSBRXBQUNFFWBD-NSHDSACASA-N 498866 US11014912, Example 42 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498866&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314459 459071745 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039154 COc1cccc(c1)-c1cc(NC(=O)C[C@H]2CCN(C2)C#N)on1 InChI=1S/C17H18N4O3/c1-23-14-4-2-3-13(8-14)15-9-17(24-20-15)19-16(22)7-12-5-6-21(10-12)11-18/h2-4,8-9,12H,5-7,10H2,1H3,(H,19,22)/t12-/m1/s1 UGTOHJBLJZBSKU-GFCCVEGCSA-N 498867 US11014912, Example 43 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498867&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 153311696 459071746 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039155 O=C(CC1CCN(C1)C#N)Nc1cc2ccccn2n1 InChI=1S/C14H15N5O/c15-10-18-6-4-11(9-18)7-14(20)16-13-8-12-3-1-2-5-19(12)17-13/h1-3,5,8,11H,4,6-7,9H2,(H,16,17,20) UKZYBBCPTLQFIY-UHFFFAOYSA-N 498868 US11014912, Example 44 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498868&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757232 459071747 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039156 FC(F)(F)c1ccnc(NC(=O)CC2CCN(C2)C#N)c1 InChI=1S/C13H13F3N4O/c14-13(15,16)10-1-3-18-11(6-10)19-12(21)5-9-2-4-20(7-9)8-17/h1,3,6,9H,2,4-5,7H2,(H,18,19,21) MQJOXKBWAMDITG-UHFFFAOYSA-N 498869 US11014912, Example 45 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498869&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757237 459071748 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039157 O=C(CC1CCN(C1)C#N)Nc1ccc(cn1)C#N InChI=1S/C13H13N5O/c14-6-11-1-2-12(16-7-11)17-13(19)5-10-3-4-18(8-10)9-15/h1-2,7,10H,3-5,8H2,(H,16,17,19) FTAMBIWLRCPYIX-UHFFFAOYSA-N 498870 US11014912, Example 46 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498870&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757201 459071749 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039158 O=C(CC1CCN(C1)C#N)NC1CN(C1)c1ccccn1 InChI=1S/C15H19N5O/c16-11-19-6-4-12(8-19)7-15(21)18-13-9-20(10-13)14-3-1-2-5-17-14/h1-3,5,12-13H,4,6-10H2,(H,18,21) MTKRNDHPLYBJFZ-UHFFFAOYSA-N 498871 US11014912, Example 47 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498871&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757217 459071750 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039159 Clc1cccc(c1)-c1nnc(NC(=O)C[C@@H]2CCN(C2)C#N)o1 InChI=1S/C15H14ClN5O2/c16-12-3-1-2-11(7-12)14-19-20-15(23-14)18-13(22)6-10-4-5-21(8-10)9-17/h1-3,7,10H,4-6,8H2,(H,18,20,22)/t10-/m0/s1 XMJJHIFQFKSSEW-JTQLQIEISA-N 498872 US11014912, Example 48 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498872&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314447 459071751 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039160 O=C(CC1CCN(C1)C#N)Nc1nnc(o1)-c1cccc(c1)C#N InChI=1S/C16H14N6O2/c17-8-11-2-1-3-13(6-11)15-20-21-16(24-15)19-14(23)7-12-4-5-22(9-12)10-18/h1-3,6,12H,4-5,7,9H2,(H,19,21,23) MKWLTURTVIPRDG-UHFFFAOYSA-N 498873 US11014912, Example 49 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498873&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314460 459071752 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039161 C[C@@H]([C@@H]1CCN(C1)C#N)C(=O)Nc1cc(no1)-c1cccc(Cl)c1 InChI=1S/C17H17ClN4O2/c1-11(13-5-6-22(9-13)10-19)17(23)20-16-8-15(21-24-16)12-3-2-4-14(18)7-12/h2-4,7-8,11,13H,5-6,9H2,1H3,(H,20,23)/t11-,13+/m0/s1 MLSIFLHNCUDDIH-WCQYABFASA-N 498874 US11014912, Example 50 Ubiquitin carboxyl-terminal hydrolase 30 Human 5.5 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498874&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 155284025 459071753 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039162 O=C(C[C@H]1CCN(C1)C#N)Nc1cc(no1)-c1cccc(c1)C#N InChI=1S/C17H15N5O2/c18-9-12-2-1-3-14(6-12)15-8-17(24-21-15)20-16(23)7-13-4-5-22(10-13)11-19/h1-3,6,8,13H,4-5,7,10H2,(H,20,23)/t13-/m1/s1 BLELHFQTUWYZOC-CYBMUJFWSA-N 498875 US11014912, Example 51 Ubiquitin carboxyl-terminal hydrolase 30 Human 5.5 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498875&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314451 459071754 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039163 O=C(C[C@@H]1CCN(C1)C#N)N1CC(C1)c1ccc(cc1)C#N InChI=1S/C17H18N4O/c18-8-13-1-3-15(4-2-13)16-10-21(11-16)17(22)7-14-5-6-20(9-14)12-19/h1-4,14,16H,5-7,9-11H2/t14-/m0/s1 HREHZCZXJKQSKD-AWEZNQCLSA-N 498876 US11014912, Example 52 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498876&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757213 459071755 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039164 C[C@H]([C@@H]1CCN(C1)C#N)C(=O)Nc1cc(no1)-c1cccc(Cl)c1 InChI=1S/C17H17ClN4O2/c1-11(13-5-6-22(9-13)10-19)17(23)20-16-8-15(21-24-16)12-3-2-4-14(18)7-12/h2-4,7-8,11,13H,5-6,9H2,1H3,(H,20,23)/t11-,13-/m1/s1 MLSIFLHNCUDDIH-DGCLKSJQSA-N 498877 US11014912, Example 53 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498877&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314448 459071756 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039165 FC(F)(F)Oc1cccc(c1)-c1cc(NC(=O)C[C@H]2CCN(C2)C#N)on1 InChI=1S/C17H15F3N4O3/c18-17(19,20)26-13-3-1-2-12(7-13)14-8-16(27-23-14)22-15(25)6-11-4-5-24(9-11)10-21/h1-3,7-8,11H,4-6,9H2,(H,22,25)/t11-/m1/s1 SSFKEWKUQZYFNY-LLVKDONJSA-N 498878 US11014912, Example 54 Ubiquitin carboxyl-terminal hydrolase 30 Human 5.5 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498878&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 153311700 459071757 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039166 O=C(C[C@H]1CCN(C1)C#N)Nc1cc(on1)-c1cccc(c1)C#N InChI=1S/C17H15N5O2/c18-9-12-2-1-3-14(6-12)15-8-16(21-24-15)20-17(23)7-13-4-5-22(10-13)11-19/h1-3,6,8,13H,4-5,7,10H2,(H,20,21,23)/t13-/m1/s1 BLSBCDNDLMGYHI-CYBMUJFWSA-N 498879 US11014912, Example 55 Ubiquitin carboxyl-terminal hydrolase 30 Human 5.5 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498879&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 142314444 459071758 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039167 O=C(C[C@@H]1CCN(C1)C#N)N1CC(C1)c1cccc(c1)C#N InChI=1S/C17H18N4O/c18-8-13-2-1-3-15(6-13)16-10-21(11-16)17(22)7-14-4-5-20(9-14)12-19/h1-3,6,14,16H,4-5,7,9-11H2/t14-/m0/s1 IVOTXJWFZYQFCO-AWEZNQCLSA-N 498880 US11014912, Example 56 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498880&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757216 459071759 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039168 O=C(C[C@@H]1CCN(C1)C#N)N1CC(C1)c1ccc(cn1)C#N InChI=1S/C16H17N5O/c17-6-13-1-2-15(19-7-13)14-9-21(10-14)16(22)5-12-3-4-20(8-12)11-18/h1-2,7,12,14H,3-5,8-10H2/t12-/m0/s1 DXTDIMLMAZSPBY-LBPRGKRZSA-N 498881 US11014912, Example 57 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498881&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757218 459071760 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039169 Oc1ccc(cc1)C1CN(C1)C(=O)CC1CCN(C1)C#N InChI=1S/C16H19N3O2/c17-11-18-6-5-12(8-18)7-16(21)19-9-14(10-19)13-1-3-15(20)4-2-13/h1-4,12,14,20H,5-10H2 YNVVVXSPWFMQKP-UHFFFAOYSA-N 498882 US11014912, Example 58 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498882&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757209 459071761 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039170 Cc1cc(ccc1C#N)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C18H20N4O/c1-13-6-15(2-3-16(13)8-19)17-10-22(11-17)18(23)7-14-4-5-21(9-14)12-20/h2-3,6,14,17H,4-5,7,9-11H2,1H3/t14-/m0/s1 NLUWQVAMHXXCDH-AWEZNQCLSA-N 498883 US11014912, Example 59 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498883&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757205 459071762 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039171 CN(C)C(=O)c1ccc(cc1)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C19H24N4O2/c1-21(2)19(25)16-5-3-15(4-6-16)17-11-23(12-17)18(24)9-14-7-8-22(10-14)13-20/h3-6,14,17H,7-12H2,1-2H3/t14-/m0/s1 JUWHJTKPALEDBO-AWEZNQCLSA-N 498884 US11014912, Example 60 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498884&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757248 459071763 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039172 CC([C@@H]1CCN(C1)C#N)C(=O)N1CC(C1)c1ccc(cc1)C#N InChI=1S/C18H20N4O/c1-13(16-6-7-21(9-16)12-20)18(23)22-10-17(11-22)15-4-2-14(8-19)3-5-15/h2-5,13,16-17H,6-7,9-11H2,1H3/t13?,16-/m1/s1 UUQDJBKHLYLCFD-FQNRMIAFSA-N 498885 US11014912, Example 61 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498885&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 154012994 459071764 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039173 CC([C@H]1CCN(C1)C#N)C(=O)N1CC(C1)c1ccc(cc1)C#N InChI=1S/C18H20N4O/c1-13(16-6-7-21(9-16)12-20)18(23)22-10-17(11-22)15-4-2-14(8-19)3-5-15/h2-5,13,16-17H,6-7,9-11H2,1H3/t13?,16-/m0/s1 UUQDJBKHLYLCFD-VYIIXAMBSA-N 498891 US11014912, Example 62 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498891&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 162369425 459071770 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039174 O=C(C[C@H]1CCN(C1)C#N)Nc1nnc(s1)-c1ccccc1 InChI=1S/C15H15N5OS/c16-10-20-7-6-11(9-20)8-13(21)17-15-19-18-14(22-15)12-4-2-1-3-5-12/h1-5,11H,6-9H2,(H,17,19,21)/t11-/m1/s1 ZFIXWRFMOBNIJI-LLVKDONJSA-N 498886 US11014912, Example 63 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498886&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757198 459071765 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039175 O=C(C[C@@H]1CCN(C1)C#N)Nc1nnc(s1)-c1ccccc1 InChI=1S/C15H15N5OS/c16-10-20-7-6-11(9-20)8-13(21)17-15-19-18-14(22-15)12-4-2-1-3-5-12/h1-5,11H,6-9H2,(H,17,19,21)/t11-/m0/s1 ZFIXWRFMOBNIJI-NSHDSACASA-N 498892 US11014912, Example 64 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498892&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757253 459071771 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039176 CC(C)Oc1ccc(nc1)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C18H24N4O2/c1-13(2)24-16-3-4-17(20-8-16)15-10-22(11-15)18(23)7-14-5-6-21(9-14)12-19/h3-4,8,13-15H,5-7,9-11H2,1-2H3/t14-/m0/s1 VUEWGNVFAGRIAI-AWEZNQCLSA-N 498887 US11014912, Example 65 Ubiquitin carboxyl-terminal hydrolase 30 Human 550 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498887&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757260 459071766 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039177 COCCOc1ccc(cc1)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C19H25N3O3/c1-24-8-9-25-18-4-2-16(3-5-18)17-12-22(13-17)19(23)10-15-6-7-21(11-15)14-20/h2-5,15,17H,6-13H2,1H3/t15-/m0/s1 KMZSCDNRMLSZIP-HNNXBMFYSA-N 498888 US11014912, Example 66 Ubiquitin carboxyl-terminal hydrolase 30 Human 5500 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498888&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757206 459071767 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039178 COc1ccc(cc1-c1cnn(C)c1)C1CN(C1)C(=O)C[C@@H]1CCN(C1)C#N InChI=1S/C21H25N5O2/c1-24-11-17(9-23-24)19-8-16(3-4-20(19)28-2)18-12-26(13-18)21(27)7-15-5-6-25(10-15)14-22/h3-4,8-9,11,15,18H,5-7,10,12-13H2,1-2H3/t15-/m0/s1 QQUMGYBAAANUTG-HNNXBMFYSA-N 498889 US11014912, Example 67 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498889&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757234 459071768 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 1039179 COc1cccc(C2CN(C2)C(=O)C[C@@H]2CCN(C2)C#N)c1F InChI=1S/C17H20FN3O2/c1-23-15-4-2-3-14(17(15)18)13-9-21(10-13)16(22)7-12-5-6-20(8-12)11-19/h2-4,12-13H,5-10H2,1H3/t12-/m0/s1 OBYZNAAMRLKAHI-LBPRGKRZSA-N 498890 US11014912, Example 68 Ubiquitin carboxyl-terminal hydrolase 30 Human 55 US Patent 10.7270/Q2ZW1Q27 aid1805582 US11014912 Stockley, ML; Kemp, MI; Madin, A; Woodrow, MD; Jones, A 5/25/2021 11/22/2021 MISSION THERAPEUTICS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498890&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 141757235 459071769 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 5OHP Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3